慢性阻塞性肺病和肺高血压:生物标志物和临床指标的比较研究
Yingjun Huang1, Binbin Qin1, Bin Shen1
1Department of Respiratory Medicine Shanghai Second People's Hospital Shanghai China.
Pulmonary circulation
|January 26, 2026
概括
像B型尿素 (BNP) 这样的生物标志物对于诊断慢性阻塞性肺病 (AECOPD) 急性恶化的肺高血压 (PH) 是至关重要的. 在PH患者中,BNP与热素I和D-二聚合物一起显示出显著的诊断价值.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
背景情况:
- 慢性阻塞性肺病 (AECOPD) 的急性恶化经常导致肺高血压 (PH),增加患者的发病率和死亡率.
- 了解与AECOPD中不同PH严重程度相关的生物标志物概况对于改善诊断和管理至关重要.
研究的目的:
- 评估不同程度的PH的AECOPD患者的生物标志物概况,临床特征和凝血和炎症标志物的诊断疗效.
- 在AECOPD人群中评估PH的关键生物标志物的诊断精度.
主要方法:
- 一组248名AECOPD患者根据PH严重程度分为三组.
- 分析了B型尿素 (BNP),Troponin I (TNT-I),d-dimer,C反应蛋白 (CRP) 和凝血标记物的水平.
- 采用接收器操作特征 (ROC) 曲线分析来确定这些PH生物标志物的诊断准确性.
主要成果:
- 患有PH的患者比没有PH的患者年龄大得多.
- 观察到BNP,TNT-I,CRP和D-二元的水平升高,随着PH的严重程度而增加.
- 对于PH,BNP的诊断准确度最高 (AUC = 0.803),其次是TNT-I (AUC = 0.712) 和D-二次数 (AUC = 0.694).
结论:
- B型尿素 (BNP) 是诊断AECOPD患者PH的最重要的生物标志物,TNT-I和D-二次体作为有价值的二次标志物.
- 升高的凝血和炎症标志物表明它们在AECOPD背景下参与PH的病变发生.
相关概念视频
Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.4K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.4K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K


